Zhao Zhiqing, Yan Taiqiang, Guo Wei, Yang Rongli, Tang Xiaodong, Wang Wei
Musculoskeletal Tumor Center, Beijing Key Laboratory for Musculoskeletal Tumors, Peking University People's Hospital, Beijing, China.
J Bone Oncol. 2018 Dec 4;14:100209. doi: 10.1016/j.jbo.2018.100209. eCollection 2019 Feb.
Primary malignant or aggressive benign bone tumors rarely occur in distal tibia, and limb salvage remains the mainstay of surgical options. However, reconstruction methods for large bone defect after wide tumor resection in this location are debatable. The purpose of this systematical review is to critically evaluate each reconstruction method regarding the postoperative complications and functional outcome.
A systematic review of the 33 studies including 337 cases with tumors affecting distal tibia was performed after searching the PubMed and EMBASE databases. Pooled descriptive statistics with separate analyses for postoperative complications and functional outcome of different reconstruction options were performed.
290 (86.1%) patients received limb salvage procedures. Reconstruction strategies including biological reconstruction, such as autograft, allograft, distraction osteogenesis and non-biological prosthetic replacement. The patients received limb salvage procedures tended to have a higher MSTS score (77.1% vs 70.9%, = .055) and a higher incidence of local relapse (28/290 vs 0/47, = .052) than those amputated. Biological reconstruction methods provided better functional outcome (78.4% vs 72.2%, = .017) compared with non-biological prosthetic reconstruction, although similarity of incidence of major complications (51/253 vs 12/37, = .091). With respect to the comparison between autograft and allograft reconstruction, the autograft seemed to have less major postoperative complications occurrence (27/165 vs 22/78, = .032), and consequently better functional outcome (MSTS score, 80.2% vs 74.3%, = .025) than allograft reconstruction.
Limb salvage results in better functional outcome compared with amputation. Biological reconstruction is more advocated than prosthetics replacement, and furthermore, autograft might be suggested to be the optimal reconstructive method with regard to better postoperative functional outcome and less major complications.
原发性恶性或侵袭性良性骨肿瘤很少发生于胫骨远端,保肢仍然是主要的手术选择。然而,该部位广泛肿瘤切除术后大骨缺损的重建方法仍存在争议。本系统评价的目的是严格评估每种重建方法的术后并发症和功能结局。
在检索PubMed和EMBASE数据库后,对33项研究(包括337例累及胫骨远端的肿瘤患者)进行了系统评价。对不同重建方案的术后并发症和功能结局进行了汇总描述性统计分析。
290例(86.1%)患者接受了保肢手术。重建策略包括生物重建,如自体骨移植、异体骨移植、牵张成骨和非生物假体置换。与接受截肢手术的患者相比,接受保肢手术的患者倾向于有更高的肌肉骨骼肿瘤学会(MSTS)评分(77.1%对70.9%,P = 0.055)和更高的局部复发率(28/290对0/47,P = 0.052)。与非生物假体重建相比,生物重建方法提供了更好的功能结局(78.4%对72.2%,P = 0.017),尽管主要并发症发生率相似(51/253对12/37,P = 0.091)。关于自体骨移植和异体骨移植重建的比较,自体骨移植术后主要并发症的发生率似乎更低(27/165对22/78,P = 0.032),因此功能结局更好(MSTS评分,80.2%对74.3%,P = 0.025)。
与截肢相比,保肢可带来更好的功能结局。生物重建比假体置换更值得提倡,此外,就更好的术后功能结局和更少的主要并发症而言,自体骨移植可能是最佳的重建方法。